Deaths from Ebola in the Democratic Republic of Congo have approached 3,000 as Congo battles its fastest-growing outbreak on record. The epidemic is caused by the rare Bundibugyo strain, for which no approved vaccine or specific treatment exists. WHO says vaccine trials are imminent, with Oxford researchers administering the first experimental dose to a volunteer in Britain. Additional candidates are expected to enter accelerated trials. Insecurity, attacks on treatment centers, healthcare access and public mistrust are hampering efforts to contain transmission.
Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.



